Daniel J. Lee, MD
Cost considerations in the management of bladder cancer
"We will review the evidence and identify potential areas of improvement that can help reduce costs associated with UCB management while improving outcomes," write Daniel J. Lee, MD, and Sam S. Chang, MD.

Poll

View Results